Parasitology articles » Iran » Plasmodium vivax »

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
#Title
1 Basseri ,H.R. ,Doosti ,S. ,Akbarzadeh ,K. ,Nateghpour ,M. ,Whitten ,M.M. ,Ladoni ,H. (2008)Competency of Anopheles stephensi mysorensis strain for Plasmodium vivax and the role of inhibitory carbohydrates to block its sporogonic cycle, Malar J. ,7,131.
2 Ebrahimzadeh ,A. ,Fouladi ,B. ,Fazaeli ,A. (2007)High rate of detection of mixed infections of Plasmodium vivax and Plasmodium falciparum in South-East of Iran, using nested PCR, Parasitol Int. ,56(1),61-4.
3 Haghdoost ,A.A. ,Alexander ,N. (2007)Systematic review and meta-analysis of the interaction between Plasmodium falciparum and Plasmodium vivax in humans, J Vector Borne Dis. ,44(1),33-43.
4 Haghdoost ,A.A. ,Mazhari ,S. ,Bahaadini ,K. (2006)Estimating the relapse risk of Plasmodium vivax in Iran under national chemotherapy scheme using a novel method, J Vector Borne Dis. ,43(4),168-72.
5 Haghdoost ,A.A. ,Mazhari ,S. ,Bahadini ,K. (2006)Comparing the results of light microscopy with the results of PCR method in the diagnosis of Plasmodium vivax, J Vector Borne Dis. , 43(2),53-7.
6 Hamedi ,Y. ,Nateghpour ,M. ,Soonthornsata ,B. ,Tan-ariya ,P. ,Kojima ,S. , Chindanond ,D. ,Looareesuwan ,S. (2003)Monitoring of Plasmodium vivax sensitivity to chloroquine in vitro in Thailand, Trans R Soc Trop Med Hyg. ,97(4),435-7.
7 Hamedi ,Y. ,Nateghpour ,M. ,Tan-ariya ,P. ,Tiensuwan ,M. ,Silachamroon ,U. ,Looareesuwan ,S. (1999)Plasmodium vivax malaria in Southeast Iran in 1999-2001: establishing the response to chloroquine in vitro and in vivo, Southeast Asian J Trop Med Public Health. ,33(3),pp. 512-8.
8 Hamedi ,Y. ,Nateghpour ,M. ,Tan-ariya ,P. ,Tiensuwan ,M. ,Silachamroon ,U. ,Looareesuwan ,S. (2002)Plasmodium vivax malaria in Southeast Iran in 1999-2001: establishing the response to chloroquine in vitro and in vivo, Southeast Asian J Trop Med Public Health. ,33(3),512-8.
9 Hamedi ,Y. ,Safa ,O. ,Zare ,S. ,Tan-ariya ,P. ,Kojima ,S. ,Looareesuwan ,S. (2004)Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand, Southeast Asian J Trop Med Public Health. ,35(3),570-4.
10 Zakeri ,S. ,Abouie ,Mehrizi ,A. ,Djadid ,N.D. ,Snounou ,G. (2006)Circumsporozoite protein gene diversity among temperate and tropical Plasmodium vivax isolates from Iran, Trop Med Int Health. ,11(5),729-37.
11 Zakeri ,S. ,Barjesteh ,H. ,Djadid ,N.D. (2006)Merozoite surface protein-3alpha is a reliable marker for population genetic analysis of Plasmodium vivax, Malar J. ,5,53.
12 Zakeri ,S. ,Dinparast ,Djadid ,N. ,Zeinali ,S. (2003)Sequence heterogeneity of the merozoite surface protein-1 gene (MSP-1) of Plasmodium vivax wild isolates in southeastern Iran, Acta Trop. ,88(1),91-7.
13 Zakeri ,S. ,Mamaghani ,S. ,Mehrizi ,A.A. ,Shahsavari ,Z. ,Raeisi ,A. ,Arshi ,S. , Dinparast-Djadid ,N. (2004)Molecular evidence of mixed P. vivax and P. falciparum infections in northern Islamic Republic of Iran, East Mediterr Health J. ,10(3),336-42.
14 Zakeri ,S. ,Motmaen ,S.R. ,Afsharpad ,M. ,Djadid ,N.D. (2009)Molecular characterization of antifolates resistance-associated genes, (dhfr and dhps) in Plasmodium vivax isolates from the Middle East, Malar J. , 28,8,20.
15 Zakeri ,S. ,Razavi ,S. ,Djadid ,N.D. (2009)Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran, Acta Trop. ,109(3),176-80.
16 Zakeri ,S. Mehrizi ,A.A. ,Mamaghani ,S. ,Noorizadeh ,S. ,Snounou ,G. , Djadid ,N.D. (2006)Population structure analysis of Plasmodium vivax in areas of iran with different malaria endemicity,. Am J Trop Med Hyg. ,74(3),394-400.